The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group
Abstract
Importance: The Neurosarcoidosis Consortium Consensus Group, an expert panel of physicians experienced in the management of patients with sarcoidosis and neurosarcoidosis, engaged in an iterative process to define neurosarcoidosis and develop a practical diagnostic approach to patients with suspected neurosarcoidosis. This panel aimed to develop a consensus clinical definition of neurosarcoidosis to enhance the clinical care of patients with suspected neurosarcoidosis and to encourage standardization of research initiatives that address this disease. Observations: The work of this collaboration included a review of the manifestations of neurosarcoidosis and the establishment of an approach to the diagnosis of this disorder. The proposed consensus diagnostic criteria, which reflect current knowledge, provide definitions for possible, probable, and definite central and peripheral nervous system sarcoidosis. The definitions emphasize the need to evaluate patients with findings suggestive of neurosarcoidosis for alternate causal factors, including infection and malignant neoplasm. Also emphasized is the need for biopsy, whenever feasible and advisable according to clinical context and affected anatomy, of nonneural tissue to document the presence of systemic sarcoidosis and support a diagnosis of probable neurosarcoidosis or of neural tissue to support a diagnosis of definite neurosarcoidosis. Conclusions and Relevance: Diverse disease presentations and lack of specificity of relevant diagnostic tests contribute to diagnostic uncertainty. This uncertainty is compounded by the absence of a pathognomonic histologic tissue examination. The diagnostic criteria we propose are designed to focus investigations on NS as accurately as possible, recognizing that multiple pathophysiologic pathways may lead to the clinical manifestations we currently term NS. Research recognizing the clinical heterogeneity of this diagnosis may open the door to identifying meaningful biologic factors that may ultimately contribute to better treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
sarcoidosis, S. O. (1999) · American Journal of Respiratory and Critical Care Medicine · Cited by 1,953
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.ats4-99 · Cited by 1,902
Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R. P., Cordier, J. F., du Bois, R. M., Eklúnd, A., Kitaichi, M., Lynch, J. P., Rizzato, G., et al. (1999) · PubMed · Cited by 1,324
Self-citationSarcoidosis and Its Neurological Manifestations
Stern, B. J., Krumholz, A., Johns, C., Scott, P., & Nissim, J. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060080095022 · Cited by 714
Self-citationThe WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
Judson, M. A., Costabel, U., Drent, M., Wells, A. U., Maier, L. A., Koth, L. L., Shigemitsu, H., Culver, D. A., Gelfand, J. M., Valeyre, D., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 502
Self-citationSarcoidosis: A Clinicopathologic Review of Three Hundred Cases, Including Twenty-Two Autopsies
Ricker, W., & Clark, M. (1949) · American Journal of Clinical Pathology · doi:10.1093/ajcp/19.8.725 · Cited by 423
Sarcoidosis-associated fatigue
Drent, M., Lower, E. E., & De Vries, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00002512 · Cited by 285
Self-citationNext-generation sequencing in neuropathologic diagnosis of infections of the nervous system
(2016) · doi:10.1212/nxi.0000000000000251 · Cited by 171
Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment
Elfferich, M., Nelemans, P. J., Ponds, R., Vries, J. D., Wijnen, P. A. H. M., & Drent, M. (2010) · Respiration · doi:10.1159/000314225 · Cited by 148
Self-citationNeurosarcoidosis: Clinical manifestations, diagnosis and treatment
Nozaki, K., & Judson, M. A. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2011.12.017 · Cited by 124
Self-citationChopra, A., Kalkanis, A., & Judson, M. A. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1196135 · Cited by 115
Self-citationFatigue in sarcoidosis: a systematic review
de Kleijn, W. P. E., Vries, J. D., Lower, E. E., Elfferich, M., Baughman, R. P., & Drent, M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832d0403 · Cited by 112
Self-citationPeripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis
Zhou, T., Zhang, W., Sweiss, N., Chen, E. S., Möller, D. R., Knox, K. S., Ma, S., Wade, M. S., Noth, I., Machado, R. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044818 · Cited by 100
Isolated Neurosarcoidosis: Case Series in 2 Sarcoidosis Centers
Nozaki, K., Scott, T. F. M., Sohn, M., & Judson, M. A. (2012) · The Neurologist · doi:10.1097/nrl.0b013e3182704d04 · Cited by 64
Self-citationHendriks, C., Drent, M., de Kleijn, W. P. E., Elfferich, M., Wijnen, P. A. H. M., & Vries, J. D. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.11.008 · Cited by 63
Self-citationMany faces of neurosarcoidosis: from chronic meningitis to myelopathy
Fritz, D., Voortman, M., van de Beek, D., Drent, M., & Brouwer, M. C. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000401 · Cited by 50
Self-citationSzabo, B. A., Crişan, D., Tompa, I., & Szabo, I. (2011) · PubMed · Cited by 35
Cited by
Crouser, E. D., Maier, L. A., Wilson, K. C., Bonham, C. A., Morgenthau, A. S., Patterson, K. C., Abston, E., Bernstein, R. C., Blankstein, R., Chen, E. S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0251st · Cited by 1,086
Self-citationERS clinical practice guidelines on treatment of sarcoidosis
Baughman, R. P., Valeyre, D., Korsten, P., Mathioudakis, A. G., Wuyts, W. A., Wells, A., Rottoli, P., Nunes, H., Lower, E. E., Judson, M. A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04079-2020 · Cited by 629
Self-citationSarcoidosis: A Clinical Overview from Symptoms to Diagnosis
Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., et al. (2021) · Cells · doi:10.3390/cells10040766 · Cited by 487
The American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain Injury
Silverberg, N. D., Iverson, G. L., Cogan, A., Dams-O-Connor, K., Delmonico, R., Graf, M. J. P., Iaccarino, M. A., Kajankova, M., Kamins, J., McCulloch, K. L., et al. (2023) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2023.03.036 · Cited by 480
Consensus Definition of Misophonia: A Delphi Study
Swedo, S. E., Baguley, D. M., Denys, D., Dixon, L. J., Erfanian, M., Fioretti, A., Jastreboff, P. J., Kumar, S., Rosenthal, M. Z., Rouw, R., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.841816 · Cited by 249
Metadata
- Authors
- Stern, B. J., Royal, W., Gelfand, J. M., Clifford, D. B., Tavee, J., Pawate, S., Berger, J. R., Aksamit, A. J., Krumholz, A., Pardo, C. A., Moller, D. R., Judson, M. A., Drent, M., & Baughman, R. P.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-12-01
- Volume
- 75
- Issue
- 12
- Pages
- 1546
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2888794374
- Cited by
- 398
- References
- 18
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.